- Home
- TNK vs NNNN Comparison
TNK vs NNNN Comparison
Compare TNK & NNNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TNK
- NNNN
- Stock Information
- Founded
- TNK 2007
- NNNN 2021
- Country
- TNK Bermuda
- NNNN Germany
- Employees
- TNK N/A
- NNNN N/A
- Industry
- TNK Marine Transportation
- NNNN Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- TNK Consumer Discretionary
- NNNN Health Care
- Exchange
- TNK Nasdaq
- NNNN Nasdaq
- Market Cap
- TNK 2.1B
- NNNN 2.2B
- IPO Year
- TNK 2007
- NNNN 2025
- Fundamental
- Price
- TNK $57.75
- NNNN $20.91
- Analyst Decision
- TNK Strong Buy
- NNNN
- Analyst Count
- TNK 2
- NNNN 0
- Target Price
- TNK $65.00
- NNNN N/A
- AVG Volume (30 Days)
- TNK 375.8K
- NNNN 34.8K
- Earning Date
- TNK 10-29-2025
- NNNN 04-28-2026
- Dividend Yield
- TNK 3.44%
- NNNN N/A
- EPS Growth
- TNK N/A
- NNNN N/A
- EPS
- TNK 9.01
- NNNN 0.06
- Revenue
- TNK $951,879,000.00
- NNNN $8,185,146.00
- Revenue This Year
- TNK N/A
- NNNN N/A
- Revenue Next Year
- TNK N/A
- NNNN N/A
- P/E Ratio
- TNK $6.45
- NNNN $398.99
- Revenue Growth
- TNK N/A
- NNNN 21.95
- 52 Week Low
- TNK $33.35
- NNNN $5.18
- 52 Week High
- TNK $63.71
- NNNN $55.65
- Technical
- Relative Strength Index (RSI)
- TNK 43.95
- NNNN 44.83
- Support Level
- TNK $61.40
- NNNN $20.00
- Resistance Level
- TNK $63.71
- NNNN $29.38
- Average True Range (ATR)
- TNK 1.86
- NNNN 3.65
- MACD
- TNK -0.72
- NNNN 0.45
- Stochastic Oscillator
- TNK 0.50
- NNNN 41.87
About TNK Teekay Tankers Ltd.
Teekay Tankers Ltd is a provider of marine services to the international oil and natural gas industries and an operator of medium-sized oil tankers. The company operates in two segments: Tankers, which consists of the operation of all of the company's tankers (including the operations from those tankers employed on full service lightering contracts), and the company's U.S. based ship-to-ship support service operations (including its lightering support services provided as part of full service lightering operations); and Marine Services, which consists of operational and maintenance marine services provided to the Australian government, Australian energy companies and other third parties. The company generates the majority of its revenue from the Tankers segment.
About NNNN Anbio Biotechnology Class A Ordinary Shares
Anbio Biotechnology is a medical device company focused on in vitro diagnostics. It offers laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions to detect a wide range of biomarkers associated with critical medical domains encompassing infectious diseases, cancer, cardiovascular diseases, inflammation, drug abuse, endocrine disorders, renal disease, pharmacogenomics, and diabetes. Its product portfolio comprises AF-1200 Fluorescence Immunoassay Analyzer, SHA-100 Dry Chemistry Analyzer, Ferritin Rapid Test Kit, Dengue NS1 Rapid Test, Multi-HBV Rapid Test, COVID-19 Test Kit (Real-time PCR), and others. Geographically, the company generates maximum revenue from the European Union, followed by South America, Asia Pacific, North America, and other regions.